Global Prostate Specific Antigen (PSA) Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report ID: GIR2203180005 | Category: Medical Care | Pages: 111 | Format: PDF | Published Date: April 12,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Prostate Specific Antigen (PSA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Prostate Specific Antigen (PSA) Testing market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during forecast period 2022-2028. Hospitals accounting for  % of the Prostate Specific Antigen (PSA) Testing global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Radioimmunoassay segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Prostate Specific Antigen (PSA) Testing include Cleveland Diagnostics, Abbott, Siemens Healthineers, DiaSorin, and Roche Holding AG, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Prostate Specific Antigen (PSA) Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Radioimmunoassay
    Enzyme Immunoassay
Market segment by Application, can be divided into
    Hospitals
    Clinics
    Diagnostic Centers
    Research Institute
    Others
Market segment by players, this report covers
    Cleveland Diagnostics
    Abbott
    Siemens Healthineers
    DiaSorin
    Roche Holding AG
    Beckman Coulter
    Mediwatch(LABORIE)
    Boditech
    Bristol Myers Squibb
    GE Healthcare
    Endocare
    GlaxoSmith Kline
    Anixa Biosciences
    Ortho Clinical
    Fujirebio
    Merck
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Specific Antigen (PSA) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Specific Antigen (PSA) Testing, with revenue, gross margin and global market share of Prostate Specific Antigen (PSA) Testing from 2019 to 2022.
Chapter 3, the Prostate Specific Antigen (PSA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Specific Antigen (PSA) Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Prostate Specific Antigen (PSA) Testing research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Product Overview and Scope of Prostate Specific Antigen (PSA) Testing
    1.2 Classification of Prostate Specific Antigen (PSA) Testing by Type
        1.2.1 Overview: Global Prostate Specific Antigen (PSA) Testing Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Type in 2021
        1.2.3 Radioimmunoassay
        1.2.4 Enzyme Immunoassay
    1.3 Global Prostate Specific Antigen (PSA) Testing Market by Application
        1.3.1 Overview: Global Prostate Specific Antigen (PSA) Testing Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Diagnostic Centers
        1.3.5 Research Institute
        1.3.6 Others
    1.4 Global Prostate Specific Antigen (PSA) Testing Market Size & Forecast
    1.5 Global Prostate Specific Antigen (PSA) Testing Market Size and Forecast by Region
        1.5.1 Global Prostate Specific Antigen (PSA) Testing Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Prostate Specific Antigen (PSA) Testing Market Size by Region, (2017-2022)
        1.5.3 North America Prostate Specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
        1.5.4 Europe Prostate Specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
        1.5.6 South America Prostate Specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Prostate Specific Antigen (PSA) Testing Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Prostate Specific Antigen (PSA) Testing Market Drivers
        1.6.2 Prostate Specific Antigen (PSA) Testing Market Restraints
        1.6.3 Prostate Specific Antigen (PSA) Testing Trends Analysis
2 Company Profiles
    2.1 Cleveland Diagnostics
        2.1.1 Cleveland Diagnostics Details
        2.1.2 Cleveland Diagnostics Major Business
        2.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.1.4 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 Cleveland Diagnostics Recent Developments and Future Plans
    2.2 Abbott
        2.2.1 Abbott Details
        2.2.2 Abbott Major Business
        2.2.3 Abbott Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.2.4 Abbott Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Abbott Recent Developments and Future Plans
    2.3 Siemens Healthineers
        2.3.1 Siemens Healthineers Details
        2.3.2 Siemens Healthineers Major Business
        2.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.3.4 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Siemens Healthineers Recent Developments and Future Plans
    2.4 DiaSorin
        2.4.1 DiaSorin Details
        2.4.2 DiaSorin Major Business
        2.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.4.4 DiaSorin Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 DiaSorin Recent Developments and Future Plans
    2.5 Roche Holding AG
        2.5.1 Roche Holding AG Details
        2.5.2 Roche Holding AG Major Business
        2.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.5.4 Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Roche Holding AG Recent Developments and Future Plans
    2.6 Beckman Coulter
        2.6.1 Beckman Coulter Details
        2.6.2 Beckman Coulter Major Business
        2.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.6.4 Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Beckman Coulter Recent Developments and Future Plans
    2.7 Mediwatch(LABORIE)
        2.7.1 Mediwatch(LABORIE) Details
        2.7.2 Mediwatch(LABORIE) Major Business
        2.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.7.4 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Mediwatch(LABORIE) Recent Developments and Future Plans
    2.8 Boditech
        2.8.1 Boditech Details
        2.8.2 Boditech Major Business
        2.8.3 Boditech Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.8.4 Boditech Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Boditech Recent Developments and Future Plans
    2.9 Bristol Myers Squibb
        2.9.1 Bristol Myers Squibb Details
        2.9.2 Bristol Myers Squibb Major Business
        2.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.9.4 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 Bristol Myers Squibb Recent Developments and Future Plans
    2.10 GE Healthcare 
        2.10.1 GE Healthcare Details
        2.10.2 GE Healthcare Major Business
        2.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.10.4 GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 GE Healthcare Recent Developments and Future Plans
    2.11 Endocare
        2.11.1 Endocare Details
        2.11.2 Endocare Major Business
        2.11.3 Endocare Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.11.4 Endocare Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Endocare Recent Developments and Future Plans
    2.12 GlaxoSmith Kline
        2.12.1 GlaxoSmith Kline Details
        2.12.2 GlaxoSmith Kline Major Business
        2.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.12.4 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 GlaxoSmith Kline Recent Developments and Future Plans
    2.13 Anixa Biosciences
        2.13.1 Anixa Biosciences Details
        2.13.2 Anixa Biosciences Major Business
        2.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.13.4 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Anixa Biosciences Recent Developments and Future Plans
    2.14 Ortho Clinical
        2.14.1 Ortho Clinical Details
        2.14.2 Ortho Clinical Major Business
        2.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.14.4 Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Ortho Clinical Recent Developments and Future Plans
    2.15 Fujirebio
        2.15.1 Fujirebio Details
        2.15.2 Fujirebio Major Business
        2.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.15.4 Fujirebio Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Fujirebio Recent Developments and Future Plans
    2.16 Merck
        2.16.1 Merck Details
        2.16.2 Merck Major Business
        2.16.3 Merck Prostate Specific Antigen (PSA) Testing Product and Solutions
        2.16.4 Merck Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Merck Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Prostate Specific Antigen (PSA) Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Prostate Specific Antigen (PSA) Testing Players Market Share in 2021
        3.2.2 Top 10 Prostate Specific Antigen (PSA) Testing Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Prostate Specific Antigen (PSA) Testing Players Head Office, Products and Services Provided
    3.4 Prostate Specific Antigen (PSA) Testing Mergers & Acquisitions
    3.5 Prostate Specific Antigen (PSA) Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Prostate Specific Antigen (PSA) Testing Revenue and Market Share by Type (2017-2022)
    4.2 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Application (2017-2022)
    5.2 Global Prostate Specific Antigen (PSA) Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Prostate Specific Antigen (PSA) Testing Revenue by Type (2017-2028)
    6.2 North America Prostate Specific Antigen (PSA) Testing Revenue by Application (2017-2028)
    6.3 North America Prostate Specific Antigen (PSA) Testing Market Size by Country
        6.3.1 North America Prostate Specific Antigen (PSA) Testing Revenue by Country (2017-2028)
        6.3.2 United States Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        6.3.3 Canada Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        6.3.4 Mexico Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Prostate Specific Antigen (PSA) Testing Revenue by Type (2017-2028)
    7.2 Europe Prostate Specific Antigen (PSA) Testing Revenue by Application (2017-2028)
    7.3 Europe Prostate Specific Antigen (PSA) Testing Market Size by Country
        7.3.1 Europe Prostate Specific Antigen (PSA) Testing Revenue by Country (2017-2028)
        7.3.2 Germany Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        7.3.3 France Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        7.3.5 Russia Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        7.3.6 Italy Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Revenue by Type (2017-2028)
    8.2 Asia-Pacific Prostate Specific Antigen (PSA) Testing Revenue by Application (2017-2028)
    8.3 Asia-Pacific Prostate Specific Antigen (PSA) Testing Market Size by Region
        8.3.1 Asia-Pacific Prostate Specific Antigen (PSA) Testing Revenue by Region (2017-2028)
        8.3.2 China Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        8.3.3 Japan Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        8.3.4 South Korea Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        8.3.5 India Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        8.3.7 Australia Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Prostate Specific Antigen (PSA) Testing Revenue by Type (2017-2028)
    9.2 South America Prostate Specific Antigen (PSA) Testing Revenue by Application (2017-2028)
    9.3 South America Prostate Specific Antigen (PSA) Testing Market Size by Country
        9.3.1 South America Prostate Specific Antigen (PSA) Testing Revenue by Country (2017-2028)
        9.3.2 Brazil Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        9.3.3 Argentina Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue by Type (2017-2028)
    10.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue by Application (2017-2028)
    10.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Country
        10.3.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue by Country (2017-2028)
        10.3.2 Turkey Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
        10.3.4 UAE Prostate Specific Antigen (PSA) Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Prostate Specific Antigen (PSA) Testing Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?